4
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001415889-24-030211
President and CEO sold 25,000 shares at $56.19 ($1,404,805)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Campbell David Alan · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-24 | Sale : show line 1 in the form 10b5-1 | −25,000 | $56.19 | $1,404,805 | 217,054 | D |
| Open-market sales · 25,000 sh · avg $56.19 · $1,404,805 | ||||||
Loading xslF345X05/form4-12272024_081201.xml…